IL311538A

IL311538A - Multitransgenic pigs comprising ten genetic modifications for xenotransplantation

Multitransgenic pigs comprising ten genetic modifications for xenotransplantation

Info

Publication number: IL311538A
Authority: IL; Israel
Prior art keywords: promoter; transgene; transgenes; human; transgenic
Prior art date: 2021-09-20

Application number

IL311538A

Other languages

English (en)

Hebrew (he)

Inventor

Maria Kokkinaki

Kasinath V Kuravi

Original Assignee

Revivicor Inc

Maria Kokkinaki

Kasinath V Kuravi

Priority date

2021-09-20

Filing date

2022-09-19

Publication date

2024-05-01

2022-09-19 Application filed by Revivicor Inc, Maria Kokkinaki, Kasinath V Kuravi filed Critical Revivicor Inc

2024-05-01 Publication of IL311538A publication Critical patent/IL311538A/en

Links

230000009261 transgenic effect Effects 0.000 title claims description 273
238000002689 xenotransplantation Methods 0.000 title claims description 56
241000282887 Suidae Species 0.000 title description 48
230000004077 genetic alteration Effects 0.000 title description 8
231100000118 genetic alteration Toxicity 0.000 title description 8
108700019146 Transgenes Proteins 0.000 claims description 563
241001465754 Metazoa Species 0.000 claims description 368
230000014509 gene expression Effects 0.000 claims description 313
108090000623 proteins and genes Proteins 0.000 claims description 201
210000004027 cell Anatomy 0.000 claims description 193
238000012239 gene modification Methods 0.000 claims description 149
230000005017 genetic modification Effects 0.000 claims description 148
235000013617 genetically modified food Nutrition 0.000 claims description 148
210000001519 tissue Anatomy 0.000 claims description 147
210000000056 organ Anatomy 0.000 claims description 140
239000013598 vector Substances 0.000 claims description 132
241000282414 Homo sapiens Species 0.000 claims description 120
108090000765 processed proteins & peptides Proteins 0.000 claims description 118
239000003146 anticoagulant agent Substances 0.000 claims description 104
229940127219 anticoagulant drug Drugs 0.000 claims description 104
238000000034 method Methods 0.000 claims description 90
239000004074 complement inhibitor Substances 0.000 claims description 64
230000001939 inductive effect Effects 0.000 claims description 64
108010068542 Somatotropin Receptors Proteins 0.000 claims description 63
239000003018 immunosuppressive agent Substances 0.000 claims description 62
229940045513 CTLA4 antagonist Drugs 0.000 claims description 61
101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 61
108010079274 Thrombomodulin Proteins 0.000 claims description 61
102000012607 Thrombomodulin Human genes 0.000 claims description 61
102100020948 Growth hormone receptor Human genes 0.000 claims description 60
230000037431 insertion Effects 0.000 claims description 59
238000003780 insertion Methods 0.000 claims description 59
108010009900 Endothelial Protein C Receptor Proteins 0.000 claims description 58
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 57
229960003444 immunosuppressant agent Drugs 0.000 claims description 56
238000010348 incorporation Methods 0.000 claims description 54
230000001861 immunosuppressant effect Effects 0.000 claims description 51
230000001404 mediated effect Effects 0.000 claims description 48
102100025509 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Human genes 0.000 claims description 47
238000010362 genome editing Methods 0.000 claims description 47
108020004414 DNA Proteins 0.000 claims description 46
102000009839 Endothelial Protein C Receptor Human genes 0.000 claims description 46
101000856513 Homo sapiens Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase Proteins 0.000 claims description 46
108091033409 CRISPR Proteins 0.000 claims description 44
239000012634 fragment Substances 0.000 claims description 44
210000002216 heart Anatomy 0.000 claims description 42
230000001105 regulatory effect Effects 0.000 claims description 41
229940124073 Complement inhibitor Drugs 0.000 claims description 40
230000001120 cytoprotective effect Effects 0.000 claims description 39
108060003306 Galactosyltransferase Proteins 0.000 claims description 35
102100030951 Tissue factor pathway inhibitor Human genes 0.000 claims description 35
108010013555 lipoprotein-associated coagulation inhibitor Proteins 0.000 claims description 35
102000030902 Galactosyltransferase Human genes 0.000 claims description 34
210000004072 lung Anatomy 0.000 claims description 34
238000002054 transplantation Methods 0.000 claims description 34
230000004048 modification Effects 0.000 claims description 31
238000012986 modification Methods 0.000 claims description 31
238000004519 manufacturing process Methods 0.000 claims description 29
125000003729 nucleotide group Chemical group 0.000 claims description 29
108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 28
108091028043 Nucleic acid sequence Proteins 0.000 claims description 27
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 27
238000012217 deletion Methods 0.000 claims description 27
230000037430 deletion Effects 0.000 claims description 27
239000002773 nucleotide Substances 0.000 claims description 26
102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 claims description 25
108010018924 Heme Oxygenase-1 Proteins 0.000 claims description 25
101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 claims description 25
210000003734 kidney Anatomy 0.000 claims description 25
-1 DAF (CD55) Proteins 0.000 claims description 24
102000002737 Heme Oxygenase-1 Human genes 0.000 claims description 24
238000003776 cleavage reaction Methods 0.000 claims description 24
102000007625 Hirudins Human genes 0.000 claims description 23
108010007267 Hirudins Proteins 0.000 claims description 23
101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims description 23
101001012038 Homo sapiens Endothelial protein C receptor Proteins 0.000 claims description 23
108010068144 beta-1,4-N-acetyl-galactosaminyl transferase 2 Proteins 0.000 claims description 23
230000003511 endothelial effect Effects 0.000 claims description 23
229940006607 hirudin Drugs 0.000 claims description 23
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims description 23
102000051068 human PROCR Human genes 0.000 claims description 23
230000007017 scission Effects 0.000 claims description 22
102100022002 CD59 glycoprotein Human genes 0.000 claims description 18
108020005004 Guide RNA Proteins 0.000 claims description 18
230000034431 double-strand break repair via homologous recombination Effects 0.000 claims description 18
238000006467 substitution reaction Methods 0.000 claims description 18
101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 claims description 17
102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 claims description 17
238000002744 homologous recombination Methods 0.000 claims description 17
230000006801 homologous recombination Effects 0.000 claims description 17
238000005215 recombination Methods 0.000 claims description 17
238000010354 CRISPR gene editing Methods 0.000 claims description 16
210000002889 endothelial cell Anatomy 0.000 claims description 16
210000004185 liver Anatomy 0.000 claims description 15
101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 claims description 14
102000044459 human CD47 Human genes 0.000 claims description 14
230000035772 mutation Effects 0.000 claims description 14
210000000496 pancreas Anatomy 0.000 claims description 14
101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 claims description 13
238000003209 gene knockout Methods 0.000 claims description 12
238000010374 somatic cell nuclear transfer Methods 0.000 claims description 12
102100039373 Membrane cofactor protein Human genes 0.000 claims description 11
102000044446 human CD46 Human genes 0.000 claims description 11
230000002792 vascular Effects 0.000 claims description 11
241000124008 Mammalia Species 0.000 claims description 10
239000004098 Tetracycline Substances 0.000 claims description 10
229960002180 tetracycline Drugs 0.000 claims description 10
229930101283 tetracycline Natural products 0.000 claims description 10
235000019364 tetracycline Nutrition 0.000 claims description 10
150000003522 tetracyclines Chemical class 0.000 claims description 10
101800001494 Protease 2A Proteins 0.000 claims description 9
101800001066 Protein 2A Proteins 0.000 claims description 9
239000012212 insulator Substances 0.000 claims description 9
230000001537 neural effect Effects 0.000 claims description 9
238000011282 treatment Methods 0.000 claims description 9
SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims description 8
102100031780 Endonuclease Human genes 0.000 claims description 8
108010042407 Endonucleases Proteins 0.000 claims description 8
101001079623 Homo sapiens Heme oxygenase 1 Proteins 0.000 claims description 8
229960003722 doxycycline Drugs 0.000 claims description 8
102000053305 human HMOX1 Human genes 0.000 claims description 8
101000824316 Caenorhabditis elegans Omega-3 fatty acid desaturase fat-1 Proteins 0.000 claims description 7
101100481408 Danio rerio tie2 gene Proteins 0.000 claims description 6
101100386242 Homo sapiens CD55 gene Proteins 0.000 claims description 6
101100481410 Mus musculus Tek gene Proteins 0.000 claims description 6
241001504519 Papio ursinus Species 0.000 claims description 6
230000004069 differentiation Effects 0.000 claims description 6
102000051442 human CD59 Human genes 0.000 claims description 6
210000001082 somatic cell Anatomy 0.000 claims description 6
101000763314 Homo sapiens Thrombomodulin Proteins 0.000 claims description 5
102100037872 Intercellular adhesion molecule 2 Human genes 0.000 claims description 5
101710148794 Intercellular adhesion molecule 2 Proteins 0.000 claims description 5
210000003709 heart valve Anatomy 0.000 claims description 5
102000051206 human THBD Human genes 0.000 claims description 5
230000002207 retinal effect Effects 0.000 claims description 5
238000010356 CRISPR-Cas9 genome editing Methods 0.000 claims description 4
241000282693 Cercopithecidae Species 0.000 claims description 4
230000013120 recombinational repair Effects 0.000 claims description 4
230000010412 perfusion Effects 0.000 claims description 2
101000902205 Homo sapiens Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase Proteins 0.000 claims 12
102100022247 Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase Human genes 0.000 claims 12
101000718529 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) Alpha-galactosidase Proteins 0.000 description 76
241000282898 Sus scrofa Species 0.000 description 73
NNISLDGFPWIBDF-MPRBLYSKSA-N alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc Chemical compound O[C@@H]1[C@@H](NC(=O)C)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@@H](CO)O1 NNISLDGFPWIBDF-MPRBLYSKSA-N 0.000 description 63
230000002829 reductive effect Effects 0.000 description 54
101710168055 Cytidine monophosphate-N-acetylneuraminic acid hydroxylase Proteins 0.000 description 43
230000000295 complement effect Effects 0.000 description 43
150000007523 nucleic acids Chemical class 0.000 description 42
102000004169 proteins and genes Human genes 0.000 description 41
210000001744 T-lymphocyte Anatomy 0.000 description 29
230000008685 targeting Effects 0.000 description 24
102000039446 nucleic acids Human genes 0.000 description 23
108020004707 nucleic acids Proteins 0.000 description 23
229940121354 immunomodulator Drugs 0.000 description 22
230000006870 function Effects 0.000 description 21
239000002955 immunomodulating agent Substances 0.000 description 20
102000040430 polynucleotide Human genes 0.000 description 20
108091033319 polynucleotide Proteins 0.000 description 20
239000002157 polynucleotide Substances 0.000 description 20
102000004196 processed proteins & peptides Human genes 0.000 description 20
238000013518 transcription Methods 0.000 description 19
230000035897 transcription Effects 0.000 description 19
108091023040 Transcription factor Proteins 0.000 description 18
230000024203 complement activation Effects 0.000 description 18
230000037361 pathway Effects 0.000 description 18
108010047303 von Willebrand Factor Proteins 0.000 description 18
102100036537 von Willebrand factor Human genes 0.000 description 18
102000040945 Transcription factor Human genes 0.000 description 17
230000010354 integration Effects 0.000 description 17
229960001134 von willebrand factor Drugs 0.000 description 17
108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
238000010459 TALEN Methods 0.000 description 15
230000027455 binding Effects 0.000 description 15
239000003623 enhancer Substances 0.000 description 15
239000003112 inhibitor Substances 0.000 description 15
238000009395 breeding Methods 0.000 description 14
230000001488 breeding effect Effects 0.000 description 14
230000002584 immunomodulator Effects 0.000 description 14
241000282412 Homo Species 0.000 description 13
241000699670 Mus sp. Species 0.000 description 13
108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 13
230000000694 effects Effects 0.000 description 13
230000002068 genetic effect Effects 0.000 description 13
210000004379 membrane Anatomy 0.000 description 13
239000012528 membrane Substances 0.000 description 13
230000006798 recombination Effects 0.000 description 13
102100030024 Endothelial protein C receptor Human genes 0.000 description 12
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
108010042591 activated protein C receptor Proteins 0.000 description 12
230000006907 apoptotic process Effects 0.000 description 12
238000005516 engineering process Methods 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
239000003550 marker Substances 0.000 description 12
230000004083 survival effect Effects 0.000 description 12
108700028369 Alleles Proteins 0.000 description 11
206010061218 Inflammation Diseases 0.000 description 11
101150045640 VWF gene Proteins 0.000 description 11
239000002299 complementary DNA Substances 0.000 description 11
244000144980 herd Species 0.000 description 11
210000002540 macrophage Anatomy 0.000 description 11
238000011830 transgenic mouse model Methods 0.000 description 11
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 10
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 10
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 10
230000004913 activation Effects 0.000 description 10
238000001994 activation Methods 0.000 description 10
210000004369 blood Anatomy 0.000 description 10
239000008280 blood Substances 0.000 description 10
230000004054 inflammatory process Effects 0.000 description 10
239000003446 ligand Substances 0.000 description 10
239000000047 product Substances 0.000 description 10
238000013519 translation Methods 0.000 description 10
241000288906 Primates Species 0.000 description 9
150000001413 amino acids Chemical group 0.000 description 9
230000003110 anti-inflammatory effect Effects 0.000 description 9
239000013604 expression vector Substances 0.000 description 9
102000034356 gene-regulatory proteins Human genes 0.000 description 9
108091006104 gene-regulatory proteins Proteins 0.000 description 9
230000001506 immunosuppresive effect Effects 0.000 description 9
230000002401 inhibitory effect Effects 0.000 description 9
229920001184 polypeptide Polymers 0.000 description 9
102000005962 receptors Human genes 0.000 description 9
108020003175 receptors Proteins 0.000 description 9
241000699660 Mus musculus Species 0.000 description 8
206010052779 Transplant rejections Diseases 0.000 description 8
108010017070 Zinc Finger Nucleases Proteins 0.000 description 8
230000006378 damage Effects 0.000 description 8
108020004999 messenger RNA Proteins 0.000 description 8
230000008569 process Effects 0.000 description 8
230000004044 response Effects 0.000 description 8
230000003612 virological effect Effects 0.000 description 8
108010039471 Fas Ligand Protein Proteins 0.000 description 7
101150082479 GAL gene Proteins 0.000 description 7
102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 description 7
101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 7
101100519207 Mus musculus Pdcd1 gene Proteins 0.000 description 7
101710163270 Nuclease Proteins 0.000 description 7
101150036449 SIRPA gene Proteins 0.000 description 7
239000000427 antigen Substances 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
230000003078 antioxidant effect Effects 0.000 description 7
238000013459 approach Methods 0.000 description 7
210000001772 blood platelet Anatomy 0.000 description 7
210000002808 connective tissue Anatomy 0.000 description 7
230000000139 costimulatory effect Effects 0.000 description 7
201000010099 disease Diseases 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
230000005782 double-strand break Effects 0.000 description 7
210000003038 endothelium Anatomy 0.000 description 7
230000002779 inactivation Effects 0.000 description 7
230000006698 induction Effects 0.000 description 7
230000007246 mechanism Effects 0.000 description 7
238000002560 therapeutic procedure Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
102000016574 Complement C3-C5 Convertases Human genes 0.000 description 6
108010067641 Complement C3-C5 Convertases Proteins 0.000 description 6
108060003951 Immunoglobulin Proteins 0.000 description 6
206010062016 Immunosuppression Diseases 0.000 description 6
108700002010 MHC class II transactivator Proteins 0.000 description 6
108090000190 Thrombin Proteins 0.000 description 6
230000001154 acute effect Effects 0.000 description 6
238000007792 addition Methods 0.000 description 6
230000000735 allogeneic effect Effects 0.000 description 6
239000003963 antioxidant agent Substances 0.000 description 6
235000006708 antioxidants Nutrition 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
230000000959 cryoprotective effect Effects 0.000 description 6
239000003814 drug Substances 0.000 description 6
229940079593 drug Drugs 0.000 description 6
108020001507 fusion proteins Proteins 0.000 description 6
102000037865 fusion proteins Human genes 0.000 description 6
210000000987 immune system Anatomy 0.000 description 6
102000018358 immunoglobulin Human genes 0.000 description 6
238000011532 immunohistochemical staining Methods 0.000 description 6
230000001976 improved effect Effects 0.000 description 6
210000004153 islets of langerhan Anatomy 0.000 description 6
210000000822 natural killer cell Anatomy 0.000 description 6
235000020660 omega-3 fatty acid Nutrition 0.000 description 6
230000036961 partial effect Effects 0.000 description 6
230000002633 protecting effect Effects 0.000 description 6
229960004072 thrombin Drugs 0.000 description 6
238000012250 transgenic expression Methods 0.000 description 6
238000011144 upstream manufacturing Methods 0.000 description 6
108010021064 CTLA-4 Antigen Proteins 0.000 description 5
102000008203 CTLA-4 Antigen Human genes 0.000 description 5
108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
101100156611 Homo sapiens VWF gene Proteins 0.000 description 5
102220606900 Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase_P2A_mutation Human genes 0.000 description 5
241000283984 Rodentia Species 0.000 description 5
108010052160 Site-specific recombinase Proteins 0.000 description 5
230000006044 T cell activation Effects 0.000 description 5
230000002424 anti-apoptotic effect Effects 0.000 description 5
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 5
230000001413 cellular effect Effects 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
206010012601 diabetes mellitus Diseases 0.000 description 5
230000004927 fusion Effects 0.000 description 5
239000005090 green fluorescent protein Substances 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
210000004940 nucleus Anatomy 0.000 description 5
230000003389 potentiating effect Effects 0.000 description 5
239000003642 reactive oxygen metabolite Substances 0.000 description 5
230000010076 replication Effects 0.000 description 5
239000004055 small Interfering RNA Substances 0.000 description 5
208000010110 spontaneous platelet aggregation Diseases 0.000 description 5
239000000126 substance Substances 0.000 description 5
238000001356 surgical procedure Methods 0.000 description 5
230000002103 transcriptional effect Effects 0.000 description 5
108010074708 B7-H1 Antigen Proteins 0.000 description 4
102000008096 B7-H1 Antigen Human genes 0.000 description 4
238000010453 CRISPR/Cas method Methods 0.000 description 4
102000004127 Cytokines Human genes 0.000 description 4
108090000695 Cytokines Proteins 0.000 description 4
230000004568 DNA-binding Effects 0.000 description 4
101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 description 4
101001117312 Homo sapiens Programmed cell death 1 ligand 2 Proteins 0.000 description 4
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
108091092195 Intron Proteins 0.000 description 4
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
208000006302 Laron syndrome Diseases 0.000 description 4
101710098610 Leukocyte surface antigen CD47 Proteins 0.000 description 4
102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 4
102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 4
101800004937 Protein C Proteins 0.000 description 4
102000017975 Protein C Human genes 0.000 description 4
241000700159 Rattus Species 0.000 description 4
101800001700 Saposin-D Proteins 0.000 description 4
102000019197 Superoxide Dismutase Human genes 0.000 description 4
108010012715 Superoxide dismutase Proteins 0.000 description 4
230000005867 T cell response Effects 0.000 description 4
208000007536 Thrombosis Diseases 0.000 description 4
241000700605 Viruses Species 0.000 description 4
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
239000000370 acceptor Substances 0.000 description 4
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
230000002776 aggregation Effects 0.000 description 4
238000004220 aggregation Methods 0.000 description 4
230000004075 alteration Effects 0.000 description 4
210000004436 artificial bacterial chromosome Anatomy 0.000 description 4
210000003719 b-lymphocyte Anatomy 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 4
210000000170 cell membrane Anatomy 0.000 description 4
239000012636 effector Substances 0.000 description 4
210000000981 epithelium Anatomy 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
230000001605 fetal effect Effects 0.000 description 4
102000043321 human CTLA4 Human genes 0.000 description 4
230000014759 maintenance of location Effects 0.000 description 4
239000013612 plasmid Substances 0.000 description 4
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
229960000856 protein c Drugs 0.000 description 4
230000009467 reduction Effects 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
230000011664 signaling Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
241000894007 species Species 0.000 description 4
230000002269 spontaneous effect Effects 0.000 description 4
238000001890 transfection Methods 0.000 description 4
229910052725 zinc Inorganic materials 0.000 description 4
239000011701 zinc Substances 0.000 description 4
102100031504 Beta-1,4 N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
108091079001 CRISPR RNA Proteins 0.000 description 3
102100035882 Catalase Human genes 0.000 description 3
108010053835 Catalase Proteins 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
230000007018 DNA scission Effects 0.000 description 3
102000052510 DNA-Binding Proteins Human genes 0.000 description 3
241000283086 Equidae Species 0.000 description 3
108700024394 Exon Proteins 0.000 description 3
241000710198 Foot-and-mouth disease virus Species 0.000 description 3
101150020003 GHR gene Proteins 0.000 description 3
108700028146 Genetic Enhancer Elements Proteins 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
108010010378 HLA-DP Antigens Proteins 0.000 description 3
102000015789 HLA-DP Antigens Human genes 0.000 description 3
108010062347 HLA-DQ Antigens Proteins 0.000 description 3
108010058597 HLA-DR Antigens Proteins 0.000 description 3
102000006354 HLA-DR Antigens Human genes 0.000 description 3
102000016761 Haem oxygenases Human genes 0.000 description 3
108050006318 Haem oxygenases Proteins 0.000 description 3
101100005713 Homo sapiens CD4 gene Proteins 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 3
206010057249 Phagocytosis Diseases 0.000 description 3
241001672814 Porcine teschovirus 1 Species 0.000 description 3
102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 3
102000018120 Recombinases Human genes 0.000 description 3
108010091086 Recombinases Proteins 0.000 description 3
206010063837 Reperfusion injury Diseases 0.000 description 3
108020004459 Small interfering RNA Proteins 0.000 description 3
230000020385 T cell costimulation Effects 0.000 description 3
241001648840 Thosea asigna virus Species 0.000 description 3
108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 3
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 3
230000021917 activation of membrane attack complex Effects 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
230000003115 biocidal effect Effects 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
230000000747 cardiac effect Effects 0.000 description 3
230000030833 cell death Effects 0.000 description 3
238000010367 cloning Methods 0.000 description 3
102000006834 complement receptors Human genes 0.000 description 3
108010047295 complement receptors Proteins 0.000 description 3
230000004540 complement-dependent cytotoxicity Effects 0.000 description 3
230000009089 cytolysis Effects 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
231100000433 cytotoxic Toxicity 0.000 description 3
230000001472 cytotoxic effect Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 3
210000003743 erythrocyte Anatomy 0.000 description 3
238000010363 gene targeting Methods 0.000 description 3
210000004602 germ cell Anatomy 0.000 description 3
230000036737 immune function Effects 0.000 description 3
230000028993 immune response Effects 0.000 description 3
229940125721 immunosuppressive agent Drugs 0.000 description 3
238000002513 implantation Methods 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
230000028709 inflammatory response Effects 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
230000003993 interaction Effects 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
230000008782 phagocytosis Effects 0.000 description 3
238000003259 recombinant expression Methods 0.000 description 3
230000008439 repair process Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
230000001732 thrombotic effect Effects 0.000 description 3
KCYOZNARADAZIZ-CWBQGUJCSA-N 2-[(2e,4e,6e,8e,10e,12e,14e)-15-(4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-2-yl)-6,11-dimethylhexadeca-2,4,6,8,10,12,14-heptaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol Chemical compound O1C2(C)CC(O)CC(C)(C)C2=CC1C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C1C=C2C(C)(C)CCCC2(C)O1 KCYOZNARADAZIZ-CWBQGUJCSA-N 0.000 description 2
101150033839 4 gene Proteins 0.000 description 2
102100032290 A disintegrin and metalloproteinase with thrombospondin motifs 13 Human genes 0.000 description 2
108091005670 ADAMTS13 Proteins 0.000 description 2
241000219195 Arabidopsis thaliana Species 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
239000002126 C01EB10 - Adenosine Substances 0.000 description 2
108010009575 CD55 Antigens Proteins 0.000 description 2
101150113197 CMAH gene Proteins 0.000 description 2
108010013423 CMPacetylneuraminate monooxygenase Proteins 0.000 description 2
101100012567 Caenorhabditis elegans fat-1 gene Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
241000282994 Cervidae Species 0.000 description 2
108010034753 Complement Membrane Attack Complex Proteins 0.000 description 2
102000000989 Complement System Proteins Human genes 0.000 description 2
108010069112 Complement System Proteins Proteins 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
KCYOZNARADAZIZ-PPBBKLJYSA-N Cryptochrome Natural products O[C@@H]1CC(C)(C)C=2[C@@](C)(O[C@H](/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(\C)/[C@H]3O[C@@]4(C)C(C(C)(C)CCC4)=C3)/C)\C)/C)C=2)C1 KCYOZNARADAZIZ-PPBBKLJYSA-N 0.000 description 2
108010037139 Cryptochromes Proteins 0.000 description 2
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
241000527994 Cyclotella gamma Species 0.000 description 2
102000018832 Cytochromes Human genes 0.000 description 2
108010052832 Cytochromes Proteins 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
108700020911 DNA-Binding Proteins Proteins 0.000 description 2
241000214054 Equine rhinitis A virus Species 0.000 description 2
108700001268 Extracellular superoxide dismutase [Cu-Zn] Proteins 0.000 description 2
102100027186 Extracellular superoxide dismutase [Cu-Zn] Human genes 0.000 description 2
102100038647 Fibroleukin Human genes 0.000 description 2
101710194522 Fibroleukin Proteins 0.000 description 2
241000237902 Hirudo medicinalis Species 0.000 description 2
101100448391 Homo sapiens GHR gene Proteins 0.000 description 2
101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 description 2
101000830570 Homo sapiens Tumor necrosis factor alpha-induced protein 3 Proteins 0.000 description 2
101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 2
101000782195 Homo sapiens von Willebrand factor Proteins 0.000 description 2
102000003839 Human Proteins Human genes 0.000 description 2
108090000144 Human Proteins Proteins 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
108010061833 Integrases Proteins 0.000 description 2
102000012330 Integrases Human genes 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
108091054438 MHC class II family Proteins 0.000 description 2
102000043131 MHC class II family Human genes 0.000 description 2
102000050019 Membrane Cofactor Human genes 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
101710146216 Membrane cofactor protein Proteins 0.000 description 2
MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 2
FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 description 2
102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 2
101000911993 Ovis aries CD59 glycoprotein Proteins 0.000 description 2
108010035766 P-Selectin Proteins 0.000 description 2
102100023472 P-selectin Human genes 0.000 description 2
241001494479 Pecora Species 0.000 description 2
102100040678 Programmed cell death protein 1 Human genes 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
108091027967 Small hairpin RNA Proteins 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 2
108700026226 TATA Box Proteins 0.000 description 2
102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 2
108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 2
206010054094 Tumour necrosis Diseases 0.000 description 2
102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
229960003697 abatacept Drugs 0.000 description 2
229960005305 adenosine Drugs 0.000 description 2
230000002411 adverse Effects 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
238000010171 animal model Methods 0.000 description 2
210000000612 antigen-presenting cell Anatomy 0.000 description 2
230000006851 antioxidant defense Effects 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
210000001106 artificial yeast chromosome Anatomy 0.000 description 2
229960005347 belatacept Drugs 0.000 description 2
102000015736 beta 2-Microglobulin Human genes 0.000 description 2
108010081355 beta 2-Microglobulin Proteins 0.000 description 2
102000005936 beta-Galactosidase Human genes 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
KCYOZNARADAZIZ-XZOHMNSDSA-N beta-cryptochrome Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C3OC4(C)CCCC(C)(C)C4=C3 KCYOZNARADAZIZ-XZOHMNSDSA-N 0.000 description 2
230000008827 biological function Effects 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
235000008429 bread Nutrition 0.000 description 2
229910002091 carbon monoxide Inorganic materials 0.000 description 2
210000004413 cardiac myocyte Anatomy 0.000 description 2
101150038500 cas9 gene Proteins 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
230000020411 cell activation Effects 0.000 description 2
230000005779 cell damage Effects 0.000 description 2
230000006037 cell lysis Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
230000015271 coagulation Effects 0.000 description 2
238000005345 coagulation Methods 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
210000004443 dendritic cell Anatomy 0.000 description 2
230000008021 deposition Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
238000006471 dimerization reaction Methods 0.000 description 2
208000009190 disseminated intravascular coagulation Diseases 0.000 description 2
210000002472 endoplasmic reticulum Anatomy 0.000 description 2
210000003989 endothelium vascular Anatomy 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
238000003198 gene knock in Methods 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
150000003278 haem Chemical class 0.000 description 2
210000005003 heart tissue Anatomy 0.000 description 2
239000004009 herbicide Substances 0.000 description 2
239000000833 heterodimer Substances 0.000 description 2
102000044949 human TNFSF10 Human genes 0.000 description 2
210000000688 human artificial chromosome Anatomy 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
230000002519 immonomodulatory effect Effects 0.000 description 2
210000002865 immune cell Anatomy 0.000 description 2
239000012642 immune effector Substances 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000002650 immunosuppressive therapy Methods 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
108091008042 inhibitory receptors Proteins 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
229910052742 iron Inorganic materials 0.000 description 2
208000028867 ischemia Diseases 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
230000007774 longterm Effects 0.000 description 2
235000009973 maize Nutrition 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
108091070501 miRNA Proteins 0.000 description 2
239000002679 microRNA Substances 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000015286 negative regulation of phagocytosis Effects 0.000 description 2
235000020665 omega-6 fatty acid Nutrition 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
210000001428 peripheral nervous system Anatomy 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
238000004321 preservation Methods 0.000 description 2
239000003805 procoagulant Substances 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000008707 rearrangement Effects 0.000 description 2
210000005084 renal tissue Anatomy 0.000 description 2
238000012552 review Methods 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
230000009919 sequestration Effects 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
230000035882 stress Effects 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000037426 transcriptional repression Effects 0.000 description 2
238000010396 two-hybrid screening Methods 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
210000003932 urinary bladder Anatomy 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
238000001262 western blot Methods 0.000 description 2
108091005957 yellow fluorescent proteins Proteins 0.000 description 2
101150039504 6 gene Proteins 0.000 description 1
206010048998 Acute phase reaction Diseases 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
102000005738 B7 Antigens Human genes 0.000 description 1
KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
102100024775 Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Human genes 0.000 description 1
102000006734 Beta-Globulins Human genes 0.000 description 1
108010087504 Beta-Globulins Proteins 0.000 description 1
GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
108010017500 Biliverdin reductase Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000282817 Bovidae Species 0.000 description 1
208000007204 Brain death Diseases 0.000 description 1
101150013553 CD40 gene Proteins 0.000 description 1
101150084532 CD47 gene Proteins 0.000 description 1
108010055167 CD59 Antigens Proteins 0.000 description 1
241000244203 Caenorhabditis elegans Species 0.000 description 1
229940122739 Calcineurin inhibitor Drugs 0.000 description 1
101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
241000282832 Camelidae Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
102000011727 Caspases Human genes 0.000 description 1
108010076667 Caspases Proteins 0.000 description 1
108030002440 Catalase peroxidases Proteins 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 1
229930105110 Cyclosporin A Natural products 0.000 description 1
108010036949 Cyclosporine Proteins 0.000 description 1
102100022286 DNA repair-scaffolding protein Human genes 0.000 description 1
101710096438 DNA-binding protein Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
241000252212 Danio rerio Species 0.000 description 1
206010011968 Decreased immune responsiveness Diseases 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
208000005189 Embolism Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000710188 Encephalomyocarditis virus Species 0.000 description 1
241001331845 Equus asinus x caballus Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
108010029144 Factor IIa Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
108010087894 Fatty acid desaturases Proteins 0.000 description 1
102000009114 Fatty acid desaturases Human genes 0.000 description 1
CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
101150042360 GGTA1 gene Proteins 0.000 description 1
101150099983 GT gene Proteins 0.000 description 1
101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
108010091714 Globoside alpha-N-acetylgalactosaminyltransferase Proteins 0.000 description 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 1
102000006587 Glutathione peroxidase Human genes 0.000 description 1
108700016172 Glutathione peroxidases Proteins 0.000 description 1
102000051366 Glycosyltransferases Human genes 0.000 description 1
108700023372 Glycosyltransferases Proteins 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
101000942118 Homo sapiens C-reactive protein Proteins 0.000 description 1
101000922020 Homo sapiens Cysteine and glycine-rich protein 1 Proteins 0.000 description 1
101000825159 Homo sapiens DNA repair-scaffolding protein Proteins 0.000 description 1
101000653189 Homo sapiens Tissue factor pathway inhibitor Proteins 0.000 description 1
101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 description 1
206010058490 Hyperoxia Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
102000009490 IgG Receptors Human genes 0.000 description 1
108010073807 IgG Receptors Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
206010022489 Insulin Resistance Diseases 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
102000004889 Interleukin-6 Human genes 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
101150069255 KLRC1 gene Proteins 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
241000288903 Lemuridae Species 0.000 description 1
241000288986 Lorisidae Species 0.000 description 1
208000004852 Lung Injury Diseases 0.000 description 1
108700005092 MHC Class II Genes Proteins 0.000 description 1
101100404845 Macaca mulatta NKG2A gene Proteins 0.000 description 1
108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100452019 Mus musculus Icam2 gene Proteins 0.000 description 1
101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
OVRNDRQMDRJTHS-KEWYIRBNSA-N N-acetyl-D-galactosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-KEWYIRBNSA-N 0.000 description 1
SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 description 1
FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 description 1
108010057466 NF-kappa B Proteins 0.000 description 1
102000003945 NF-kappa B Human genes 0.000 description 1
102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 description 1
241001045988 Neogene Species 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
108700022034 Opsonin Proteins Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
102000023159 Platelet Glycoprotein GPIb-IX Complex Human genes 0.000 description 1
108010045766 Platelet Glycoprotein GPIb-IX Complex Proteins 0.000 description 1
102000015795 Platelet Membrane Glycoproteins Human genes 0.000 description 1
108010010336 Platelet Membrane Glycoproteins Proteins 0.000 description 1
241000288935 Platyrrhini Species 0.000 description 1
108010076039 Polyproteins Proteins 0.000 description 1
102100040918 Pro-glucagon Human genes 0.000 description 1
108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
230000007022 RNA scission Effects 0.000 description 1
101001079613 Rattus norvegicus Heme oxygenase 1 Proteins 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
108091027981 Response element Proteins 0.000 description 1
241000219061 Rheum Species 0.000 description 1
241000282798 Rhinocerotidae Species 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
101000935814 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Periplasmic beta-glucosidase Proteins 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 1
241001493546 Suina Species 0.000 description 1
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
101710119418 Superoxide dismutase [Mn] Proteins 0.000 description 1
101710202572 Superoxide dismutase [Mn], mitochondrial Proteins 0.000 description 1
102100032891 Superoxide dismutase [Mn], mitochondrial Human genes 0.000 description 1
101000782193 Sus scrofa von Willebrand factor Proteins 0.000 description 1
108091008035 T cell costimulatory receptors Proteins 0.000 description 1
229940123155 T cell inhibitor Drugs 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
210000000662 T-lymphocyte subset Anatomy 0.000 description 1
102000046283 TNF-Related Apoptosis-Inducing Ligand Human genes 0.000 description 1
108010000449 TNF-Related Apoptosis-Inducing Ligand Receptors Proteins 0.000 description 1
102000002259 TNF-Related Apoptosis-Inducing Ligand Receptors Human genes 0.000 description 1
108700012411 TNFSF10 Proteins 0.000 description 1
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
241000283068 Tapiridae Species 0.000 description 1
241000288942 Tarsiidae Species 0.000 description 1
241001196954 Theilovirus Species 0.000 description 1
208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
208000001435 Thromboembolism Diseases 0.000 description 1
208000034841 Thrombotic Microangiopathies Diseases 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
206010069363 Traumatic lung injury Diseases 0.000 description 1
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
101710183617 Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 description 1
108010078334 UDP-galactose beta-D-galactosyl-1,4-glycosylceramide alpha-1,3-galactosyltransferase Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
101710185494 Zinc finger protein Proteins 0.000 description 1
102100023597 Zinc finger protein 816 Human genes 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
238000002679 ablation Methods 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
210000005006 adaptive immune system Anatomy 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
238000011316 allogeneic transplantation Methods 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
108010030291 alpha-Galactosidase Proteins 0.000 description 1
102000005840 alpha-Galactosidase Human genes 0.000 description 1
230000003321 amplification Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000006909 anti-apoptosis Effects 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000003064 anti-oxidating effect Effects 0.000 description 1
230000003409 anti-rejection Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
210000002403 aortic endothelial cell Anatomy 0.000 description 1
238000003782 apoptosis assay Methods 0.000 description 1
101150010487 are gene Proteins 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
108010087667 beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase Proteins 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
102000004558 biliverdin reductase Human genes 0.000 description 1
QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
239000003124 biologic agent Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229940126587 biotherapeutics Drugs 0.000 description 1
210000002459 blastocyst Anatomy 0.000 description 1
210000001109 blastomere Anatomy 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
150000001720 carbohydrates Chemical group 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
230000008568 cell cell communication Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000012292 cell migration Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000003399 chemotactic effect Effects 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
229960001265 ciclosporin Drugs 0.000 description 1
230000004087 circulation Effects 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
230000007012 clinical effect Effects 0.000 description 1
230000035602 clotting Effects 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
230000004154 complement system Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000004940 costimulation Effects 0.000 description 1
210000003792 cranial nerve Anatomy 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000000254 damaging effect Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000009025 developmental regulation Effects 0.000 description 1
230000037213 diet Effects 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
238000007323 disproportionation reaction Methods 0.000 description 1
230000002222 downregulating effect Effects 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
210000001339 epidermal cell Anatomy 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
239000012530 fluid Substances 0.000 description 1
102000034287 fluorescent proteins Human genes 0.000 description 1
108091006047 fluorescent proteins Proteins 0.000 description 1
235000013305 food Nutrition 0.000 description 1
210000002683 foot Anatomy 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000002980 germ line cell Anatomy 0.000 description 1
230000002641 glycemic effect Effects 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
208000006585 heme oxygenase 1 deficiency Diseases 0.000 description 1
229940025294 hemin Drugs 0.000 description 1
BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
102000048776 human CD274 Human genes 0.000 description 1
102000051143 human CRP Human genes 0.000 description 1
102000048119 human PDCD1LG2 Human genes 0.000 description 1
102000045235 human TNFAIP3 Human genes 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000000222 hyperoxic effect Effects 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000008076 immune mechanism Effects 0.000 description 1
230000007365 immunoregulation Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
210000002602 induced regulatory T cell Anatomy 0.000 description 1
230000006749 inflammatory damage Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
230000003914 insulin secretion Effects 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
208000012947 ischemia reperfusion injury Diseases 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
238000002372 labelling Methods 0.000 description 1
231100000225 lethality Toxicity 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
231100000515 lung injury Toxicity 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
108091005446 macrophage receptors Proteins 0.000 description 1
230000031852 maintenance of location in cell Effects 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
229940127554 medical product Drugs 0.000 description 1
229940126601 medicinal product Drugs 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
210000002161 motor neuron Anatomy 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
239000003471 mutagenic agent Substances 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
229940035567 orencia Drugs 0.000 description 1
210000004681 ovum Anatomy 0.000 description 1
230000010627 oxidative phosphorylation Effects 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
230000000242 pagocytic effect Effects 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
238000009521 phase II clinical trial Methods 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
210000003240 portal vein Anatomy 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000009993 protective function Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
102000005912 ran GTP Binding Protein Human genes 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
238000011552 rat model Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000019908 regulation of T cell activation Effects 0.000 description 1
230000015139 regulation of coagulation Effects 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000010410 reperfusion Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000000284 resting effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
238000009394 selective breeding Methods 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
230000007781 signaling event Effects 0.000 description 1
230000003584 silencer Effects 0.000 description 1
239000002356 single layer Substances 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
210000004894 snout Anatomy 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
210000001032 spinal nerve Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000001629 suppression Effects 0.000 description 1
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
229960001967 tacrolimus Drugs 0.000 description 1
QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000012360 testing method Methods 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
208000037816 tissue injury Diseases 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
230000003614 tolerogenic effect Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
108091006106 transcriptional activators Proteins 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000011820 transgenic animal model Methods 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
230000032258 transport Effects 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
210000003708 urethra Anatomy 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000004865 vascular response Effects 0.000 description 1
230000035899 viability Effects 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
230000036642 wellbeing Effects 0.000 description 1
238000011680 zucker rat Methods 0.000 description 1